Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Coffee, tea and maté found non-carcinogenic, unless served over 70°C

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), has evaluated the carcinogenicity of drinking coffee, maté and very hot beverages.
 
A summary of the final evaluations is published today in The Lancet Oncology, and the detailed assessments will be published as Volume 116 of the IARC Monographs.

The Working Group found no conclusive evidence for a carcinogenic effect of drinking coffee.

However, the experts did find that drinking very hot (>70°C) beverages probably causes cancer of the oesophagus in humans.

“These results suggest that drinking very hot beverages is one probable cause of oesophageal cancer and that it is the temperature, rather than the drinks themselves, that appears to be responsible,” says Dr Christopher Wild, IARC Director.
  
This was based on limited evidence from epidemiological studies that showed positive associations between cancer of the oesophagus and drinking very hot beverages.

Studies in places such as China, the Islamic Republic of Iran, Turkey, and South America, where tea or maté is traditionally drunk very hot (at about 70 °C), found that the risk of oesophageal cancer increased with the temperature at which the beverage was drunk.
 
In experiments involving animals, there was also limited evidence for the carcinogenicity of very hot water.
 
“Smoking and alcohol drinking are major causes of oesophageal cancer, particularly in many high-income countries,” stresses Dr Wild. “However, the majority of oesophageal cancers occur in parts of Asia, South America, and East Africa, where regularly drinking very hot beverages is common and where the reasons for the high incidence of this cancer are not as well understood.”
 
Oesophageal cancer is the eighth most common cause of cancer worldwide and one of the main causes of cancer death, with approximately 400 000 deaths recorded in 2012 (5% of all cancer deaths).

The proportion of oesophageal cancer cases that may be linked to drinking very hot beverages is not known.
 
Cold maté did not have carcinogenic effects in experiments on animals or in epidemiological studies, therefore drinking maté at temperatures that are not very hot was not classifiable as to its carcinogenicity to humans
 
This was based on inadequate evidence in humans for the carcinogenicity of drinking cold or warm maté and inadequate evidence in experimental animals for the carcinogenicity of cold maté as a drinking liquid.
 
Drinking coffee was similarly not classifiable as to its carcinogenicity to humans.
 
The large body of evidence currently available led to the re-evaluation of the carcinogenicity of coffee drinking, previously classified as possibly carcinogenic to humans by IARC in 1991.
 
After thoroughly reviewing more than 1000 studies in humans and animals, the Working Group found that there was inadequate evidence for the carcinogenicity of coffee drinking overall.

Many epidemiological studies showed that coffee drinking had no carcinogenic effects for cancers of the pancreas, female breast, and prostate, and reduced risks were seen for cancers of the liver and uterine endometrium.

For more than 20 other cancers, the evidence was inconclusive.

The IARC Monographs Programme seeks to classify cancer hazards, meaning the potential of any substance to cause cancer based on current knowledge.

The classification does not indicate what level of risk exists to people’s health associated with exposure to a classified hazard.

For example, IARC has classified tobacco smoking as carcinogenic to humans , but that classification does not indicate the increase in risk for each cigarette smoked.

Source: The Lancet Oncology

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation